Hungarian drugmaker Richter Gedeon Rt unveiled a new Ft 500 million biotechnology laboratory in Budapest on Friday. The laboratory, which will produce recombinant protein, was part of Ft 4.5 billion Richter has spent on biotechnology investments over the last five years, CEO Erik Bogsch said. The ceremony was attended by Minister of Economic Affairs and Transport Janós Kóka, who said knowledge and innovation constitute the real driving force for Hungary.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
